Rosemary Dineen
YOU?
Author Swipe
View article: Fertility and pregnancy in adrenal insufficiency
Fertility and pregnancy in adrenal insufficiency Open
Despite the availability of adrenal hormone replacement therapy, patients with adrenal insufficiency can be affected by reduced fertility and parity. Patients with well-managed adrenal insufficiency are expected to have uneventful pregnanc…
View article: Distinct inflammatory signatures of upper and lower body adipose tissue and adipocytes in women with normal weight or obesity
Distinct inflammatory signatures of upper and lower body adipose tissue and adipocytes in women with normal weight or obesity Open
Introduction Upper and lower body fat accumulation poses an opposing obesity-related cardiometabolic disease risk. Depot-differences in subcutaneous adipose tissue (SAT) function may underlie these associations. We aimed to investigate the…
View article: Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy Open
Background Patients with adrenal insufficiency (AI) require life-long glucocorticoid (GC) replacement therapy. Within tissues, cortisol (F) availability is under the control of the isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD). We…
View article: Response to the letter of Patra and colleagues
Response to the letter of Patra and colleagues Open
View article: A Prospective Cross-Over Study of Tissue Glucocorticoid Metabolism in Patients With Adrenal Insufficiency: The Effects of Dual-Release Hydrocortisone Therapy
A Prospective Cross-Over Study of Tissue Glucocorticoid Metabolism in Patients With Adrenal Insufficiency: The Effects of Dual-Release Hydrocortisone Therapy Open
Background: Patients with adrenal insufficiency (AI) require life-long glucocorticoid (GC) replacement therapy. Within tissues, cortisol (F) availability is under the control of the isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD). W…
View article: The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy
The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy Open
Background Glucocorticoid therapy is the most common cause of iatrogenic osteoporosis. Less is known regarding the effect of glucocorticoids when used as replacement therapy on bone remodelling in patients with adrenal insufficiency. Enhan…
View article: Fluid Restriction Therapy for Chronic SIAD; Results of a Prospective Randomized Controlled Trial
Fluid Restriction Therapy for Chronic SIAD; Results of a Prospective Randomized Controlled Trial Open
Context Fluid restriction (FR) is the recommended first-line treatment for syndrome of inappropriate antidiuresis (SIAD), despite the lack of prospective data to support its efficacy. Design A prospective nonblinded randomized controlled t…
View article: Issue Information
Issue Information Open
View article: Adrenal Incidentaloma
Adrenal Incidentaloma Open
An adrenal incidentaloma is now established as a common endocrine diagnosis that requires a multidisciplinary approach for effective management. The majority of patients can be reassured and discharged, but a personalized approach based up…
View article: The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy
The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy Open
Background: Glucocorticoid therapy is the most common cause of iatrogenic osteoporosis. Less is known regarding the effect of glucocorticoids when used as replacement therapy on bone remodelling in patients with adrenal insufficiency. Enha…
View article: MON-447 Impact Of Cortisone And Glucocorticoid Metabolites On Bone Turnover Markers in Male Patients With Hypopituitarism
MON-447 Impact Of Cortisone And Glucocorticoid Metabolites On Bone Turnover Markers in Male Patients With Hypopituitarism Open
Background: Glucocorticoid therapy is the most common cause of iatrogenic osteoporosis. Less is known on the effect of glucocorticoids on bone remodeling when used as replacement therapy in patients with adrenal insufficiency. Enhanced int…
View article: Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD
Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD Open
Background Acute hyponatremia is a medical emergency that confers high mortality, attributed primarily to cerebral edema. Expert guidelines advocate the use of intravenous boluses of hypertonic saline rather than traditional continuous inf…
View article: Adrenal crisis: prevention and management in adult patients
Adrenal crisis: prevention and management in adult patients Open
Adrenal crisis is an acute life-threatening emergency contributing to the excess mortality that is reported in patients with adrenal insufficiency. The incidence of adrenal crisis is estimated to be 8 per 100 patient years in patients with…
View article: Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy
Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy Open
Summary Glucocorticoids ( GC s) are steroid hormones, which are essential for life. They are secreted by the adrenal cortex under the control of the hypothalamic‐pituitary‐adrenal ( HPA ) axis. Glucocorticoids are essential for the normal …
View article: Ripping at the Seams: Stories of a Too-Fat, Fractured, Feminist Killjoy
Ripping at the Seams: Stories of a Too-Fat, Fractured, Feminist Killjoy Open
View article: Endocrinopathies and renal outcomes in lithium therapy: impact of lithium toxicity
Endocrinopathies and renal outcomes in lithium therapy: impact of lithium toxicity Open
Stage 3 CKD is common in patients receiving lithium therapy. Lithium toxicity is associated with CKD and hypernatraemia. Thyroid dysfunction and hypercalcaemia are common in patients receiving lithium therapy. Patients receiving lithium th…
View article: Hyponatraemia – presentations and management
Hyponatraemia – presentations and management Open
View article: ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long‐term follow‐up of 519 patients in two large European centres
ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long‐term follow‐up of 519 patients in two large European centres Open
Summary Context and Objective Nonfunctioning pituitary adenomas ( NFPA s) are the most common subtype of pituitary tumour. Hypopituitarism is observed in NFPA s due to tumour‐ or treatment‐related factors and may increase mortality risk. H…
View article: Heterogenous patterns of recovery of thirst in adult patients with adipsic diabetes insipidus
Heterogenous patterns of recovery of thirst in adult patients with adipsic diabetes insipidus Open
We report that 3/12 patients with ADI recovered thirst after longstanding adipsia with heterogenous pattern of recovery. Both the mortality of 25% and the recovery rate of 25% should be considered when planning long-term surveillance.
View article: Endocrinopathies associated with lithium therapy in an Irish tertiary referral centre
Endocrinopathies associated with lithium therapy in an Irish tertiary referral centre Open
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
View article: Cushing's disease in a 7-year-boy due to corticotroph cell hyperplasia
Cushing's disease in a 7-year-boy due to corticotroph cell hyperplasia Open
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
View article: Recurrent severe symptomatic hyponatraemia induced by low-dose oral cyclophosphamide in a patient with ANA-related vasculitis
Recurrent severe symptomatic hyponatraemia induced by low-dose oral cyclophosphamide in a patient with ANA-related vasculitis Open
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)